Diajard-L 5mg/25mg for Type 2 Diabetes & Heart Risk
Diajard-L 5mg/25mg Tablet is a fixed-dose combination of empagliflozin (SGLT2 inhibitor) and linagliptin (DPP-4 inhibitor) for adults with type 2 diabetes, particularly those at cardiovascular risk. It combines two complementary mechanisms to lower blood sugar more effectively than either drug alone. A prescription is required for this medication. Do not stop without consulting your doctor. Sick-day rule: temporarily stop during severe illness, dehydration, or when unable to eat — consult your doctor immediately. Risk of euglycaemic diabetic ketoacidosis (DKA): seek emergency care if you experience persistent nausea, vomiting, abdominal pain, or unusual fatigue. May increase risk of genital yeast infections and urinary tract infections. May cause dizziness — sit or stand up slowly.
Pay in 3 Installments of
Rs.
101
Diajard-l 5mg/25mg for Type 2 Diabetes & Heart Risk
Description
Diajard-L Tablets 5mg/25mg – Dual Action Diabetes and Heart Protection Therapy
Diajard-L Tablets 5mg/25mg are a prescription oral antidiabetic medication formulated with empagliflozin and linagliptin for the management of type 2 diabetes mellitus in adults. This dual-action therapy targets blood sugar control through complementary mechanisms while offering added cardiovascular protection for diabetic patients.
Empagliflozin works by increasing glucose excretion through the kidneys, effectively lowering blood sugar levels, while linagliptin enhances insulin release and reduces glucagon secretion in a glucose-dependent manner. Together, these agents provide balanced control of fasting and post-meal glucose levels without excessive insulin stimulation.
In addition to glycemic control, Diajard-L is also prescribed to reduce the risk of major cardiovascular events such as heart attack and stroke in patients with type 2 diabetes, particularly those with existing cardiovascular risk factors. This makes it a valuable option for patients requiring both metabolic and heart-protective benefits.
Diajard-L Tablets should be taken strictly as prescribed by a healthcare professional, along with regular blood sugar monitoring, a balanced diet, and physical activity. The dosage and duration depend on individual treatment goals and medical history.
How to Order Diajard-L 5mg/25mg at Derma.pk
At Derma.pk, we ensure the authenticity of Diajard-L Tablets 5mg/25mg, verified by licensed pharmacists. Delivery is available across Pakistan. For prescriptions or inquiries, contact sales@derma.pk or WhatsApp +92-320-5999650.
Usage & Benefits
Dual mechanism: SGLT2 inhibitor + DPP-4 inhibitor work together for stronger HbA1c reduction
Cardiovascular protection: empagliflozin has documented evidence for reducing heart failure hospitalisation
Slows chronic kidney disease progression in type 2 diabetes patients
Weight-neutral DPP-4 partner: linagliptin adds glucose-dependent insulin response without driving weight gain
Low intrinsic hypoglycaemia risk — neither component forces insulin release
Simplifies therapy by combining two separate treatments into one once-daily tablet
How To Use
Take one Diajard-L 5mg/25mg tablet once daily in the morning, with or without food. Swallow whole with a full glass of water. Do not stop without consulting your doctor. Sick-day rule: temporarily stop during severe illness, dehydration, or when unable to eat — consult your doctor immediately. Risk of euglycaemic diabetic ketoacidosis (DKA): seek emergency care if you experience persistent nausea, vomiting, abdominal pain, or unusual fatigue. May increase risk of genital yeast infections and urinary tract infections — report symptoms early. If you develop sudden severe abdominal pain, stop the tablet and contact your doctor immediately — rare pancreatitis has been linked to DPP-4 inhibitors. May cause dizziness — sit or stand up slowly. Monitor HbA1c and kidney function as advised by your doctor.
FAQs
What two drugs are in Diajard-L?
Diajard-L contains empagliflozin 5mg (SGLT2 inhibitor) and linagliptin 25mg (DPP-4 inhibitor). Together they lower blood sugar through two complementary mechanisms in a single once-daily tablet.
Is there a risk of pancreatitis with this combination?
DPP-4 inhibitors like linagliptin have been linked to rare cases of acute pancreatitis. Stop the tablet and contact your doctor immediately if you develop persistent severe abdominal pain.
What are the DKA warning signs I should watch for?
Risk of euglycaemic DKA exists due to the empagliflozin component. Seek emergency care if you experience persistent nausea, vomiting, abdominal pain, or unusual fatigue — even if your blood sugar reads normal.
Does Diajard-L protect the heart?
Yes. Empagliflozin has documented cardiovascular benefits in type 2 diabetes — it reduces the risk of heart failure hospitalisation and is often used in patients with established cardiovascular disease.
Can I take Diajard-L with insulin or sulfonylureas?
Yes, but the risk of hypoglycaemia rises when combined with insulin or sulfonylureas. Your doctor will likely reduce those doses accordingly.
Dermatologist Recommended
Healer's Pharma Minoxidil 5% + Finasteride 0.25% Hair Regrowth Spray
0.25% Finasteride Topical Hair Loss Spray by Healer's Pharma
